Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Mark Alles
Pharma
Celgene raised Revlimid's price to meet aggressive sales targets
Celgene hiked prices on its cancer blockbuster Revlimid to hit aggressive sales targets or cover for expected shortfalls, a congressional report says.
Eric Sagonowsky
Sep 30, 2020 9:30am
Taiho, Otsuka, Chugai, Biocon and Mark Alles—FiercePharmaAsia
Jan 10, 2020 10:59am
Bristol bumps Lynch, recruits Novartis vet for post-merger team
Jun 5, 2019 11:16am
BMS-Celgene integration questions? Execs aren't answering
Apr 26, 2019 11:45am
Investors aim to spotlight ties between pricing, exec pay
Apr 23, 2019 11:29am
Alexion chief nabs $16.5M in 2018
Mar 27, 2019 12:20pm
